SARS-CoV-2 in a Mink Farm in Italy: Case Description, Molecular and Serological Diagnosis by Comparing Different Tests.
Italy
SARS-CoV-2 diagnosis
mink farm
phylogenetic analysis
serology
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
08 08 2022
08 08 2022
Historique:
received:
10
06
2022
revised:
01
07
2022
accepted:
04
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
This study described a SARS-CoV-2 infection in minks on an Italian farm. Surveillance was performed based on clinical examination and a collection of 1879 swabs and 74 sera from dead and live animals. The farm was placed under surveillance for 4.5 months, from the end of July 2020, when a man working on the farm tested positive by RT-PCR, till mid-December 2020 when all the animals were sacrificed. Clinical examination revealed no clinical signs or increased mortality rates attributable to SARS-CoV-2, while diagnostic tests detected only four weak PCR-positive samples, but 100% of sera were positive for SARS-CoV-2 anti-S antibodies. The phylogenetic analysis of two SARS-CoV-2 sequences from two minks and the sequence of the worker showed that they belonged to different clades. It could be therefore assumed that two distinct introductions of the virus occurred on the farm, and that the first introduction probably occurred before the start of the surveillance period. From the data collected, and especially from the detection of specific antibodies through the combination of different tests, it can be postulated that syndromic surveillance combined with genome detection by PCR may not be sufficient to achieve a diagnosis in asymptomatic animals. In particular, the serological approach, especially when using tests directed towards the S protein, may be useful for improving the traceability of virus circulation in similar environments.
Identifiants
pubmed: 36016360
pii: v14081738
doi: 10.3390/v14081738
pmc: PMC9415545
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Travel Med Infect Dis. 2020 Sep - Oct;37:101830
pubmed: 32755673
Viruses. 2021 Aug 25;13(9):
pubmed: 34578266
PeerJ. 2020 Dec 18;8:e10609
pubmed: 33384909
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Nature. 2020 May 18;:
pubmed: 32427902
Animals (Basel). 2021 Jan 12;11(1):
pubmed: 33445704
Emerg Infect Dis. 2021 Feb;27(2):547-551
pubmed: 33207152
EFSA J. 2021 Mar 03;19(3):e06459
pubmed: 33717355
J Clin Microbiol. 1999 Nov;37(11):3634-43
pubmed: 10523566
PLoS Pathog. 2021 Nov 15;17(11):e1010068
pubmed: 34780574
Transbound Emerg Dis. 2021 Jul;68(4):1721-1725
pubmed: 33007154
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Vet Res Commun. 2021 Feb;45(1):1-19
pubmed: 33464439
Virus Res. 2021 Sep;302:198473
pubmed: 34118360
Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):
pubmed: 34732583
Animal. 2021 Jul;15(7):100272
pubmed: 34126387
J Clin Microbiol. 2002 Sep;40(9):3256-60
pubmed: 12202562
Nat Biotechnol. 2020 Sep;38(9):1073-1078
pubmed: 32704169
One Health. 2021 Dec;13:100313
pubmed: 34458548
Viruses. 2021 Aug 19;13(8):
pubmed: 34452513
Front Microbiol. 2021 Sep 20;12:675528
pubmed: 34616371
Front Microbiol. 2021 Jun 25;12:698944
pubmed: 34248922
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
J Infect Dis. 2020 Sep 14;222(8):1265-1269
pubmed: 32726417